Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.

Mr. An Guo  Huang

Chief Financial Officer & Secretary of the Board

Mr. Shi Min  Wang

Deputy General Manager

Mr. Baishen  Ouyang

Chairman of the Supervisory Board & Assistant to the GM

Mr. Jianwen  Cai

Mr. Chungeng  Chen

Supervisor & Supply Chain Director

Mr. Shao Bo  Li

Chairman & GM

Pavadinimas	Rinkos kapitalizacija
SofWave Medical Ltd.	0M
BIOLASE, Inc.	0M
Eiken Chemical Co., Ltd.	0M
Silk Road Medical, Inc	0M
Universus Photo Imagings Limited	0M
QHSLab, Inc.	0M
Qlife Holding AB (publ)	0M
Vitrolife AB (publ)	0M
ReWalk Robotics Ltd.	0M
Bone Biologics Corporation	0M

Sinocare Inc.

Sinocare Inc. Konkurentų sąrašas

Pagrindiniai konkurentai